The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Abstract
Atherosclerotic vascular disease arises as a consequence of the deposition and retention of serum lipoproteins in the artery wall. Macrophages in lesions have been shown to express > or = 6 structurally different scavenger receptors for uptake of modified forms of low-density lipoproteins (LDLs) that promote the cellular accumulation of cholesterol. Because cholesterol-laden macrophage foam cells are the primary component of the fatty streak, the earliest atherosclerotic lesion, lipid uptake by these pathways has long been considered a requisite and initiating event in the pathogenesis of atherosclerosis. Although the removal of proinflammatory modified LDLs from the artery wall via scavenger receptors would seem beneficial, the pathways distal to scavenger receptor uptake that metabolize the modified lipoproteins appear to become overwhelmed, leading to the accumulation of cholesterol-laden macrophages and establishment of a chronic inflammatory setting. These observations have led to the current dogma concerning scavenger receptors, which is that they are proatherogenic molecules. However, recent studies suggest that the effects of scavenger receptors on atherogenesis may be more complex. In addition to modified lipoprotein uptake, these proteins are now known to regulate apoptotic cell clearance, initiate signal transduction, and serve as pattern recognition receptors for pathogens, activities that may contribute both to proinflammatory and anti-inflammatory forces regulating atherogenesis. In this review, we focus on recent advances in our knowledge of scavenger receptor regulation and signal transduction, their roles in sterile inflammation and infection, and the potential impact of these pathways in regulating the balance of lipid accumulation and inflammation in the artery wall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in the levels of circulating TNF-a, IL-6, IL-2R and CRP are also strong predictors of all-cause mortality risk in longitudinal studies of several elderly cohorts (190 -193) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
An endothelial receptor for oxidized low-density lipoprotein
Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T., et al. (1997) · Nature · doi:10.1038/386073a0 · Cited by 1,386
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,282
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H. I., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,226
Kunjathoor, V., Febbraio, M., Podrez, E., Moore, K., Andersson, L., Koehn, S. L., Rhee, J. S., Silverstein, R., Hoff, H., & Freeman, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209649200 · Cited by 1,064
Self-citationFebbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,037
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M. W., Rohrer, L., Zabrecky, J. R., Matsudaira, P. T., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,036
Self-citationMichelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,014
CD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873
Research works printed but not linked: 12
- 1980, Artery, 8, 208
- 1992, Am J Pathol, 141, 591
- 10.1161/atvb.17.11.2369 · DOI
- 1998, Lab Invest, 78, 423
- 10.1161/atvb.19.8.1960 · DOI
- 10.1161/atvb.20.12.2593 · DOI
- 10.1161/atvb.20.12.2600 · DOI
- 10.1161/atvb.19.5.1299 · DOI
- 10.1161/res.90.3.270 · DOI
- 10.1161/atvb.20.3.721 · DOI
- 10.1161/circ.99.24.3110 · DOI
- 10.1161/atvb.20.4.1107 · DOI
Cited by
Sorted by citations
Items 101–200 of 563
The Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 108
Deletion of the murine scavenger receptor CD68
Song, L., Lee, C., & Schindler, C. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m015412 · Cited by 108
Joffre, J., Potteaux, S., Zeboudj, L., Loyer, X., Boufenzer, A., Laurans, L., Esposito, B., Vandestienne, M., de Jager, S. C. A., Hénique, C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.015 · Cited by 117
The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation
Lin, J., Li, M., Wang, Z., He, S., Ma, X., & Li, D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d000497 · Cited by 110
Fairé, U. D., Su, J., Hua, X., Frostegård, A. G., Halldin, M., Hellénius, M.-L., Wikström, M., Dahlbom, I., Grönlund, H., & Frostegård, J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.05.003 · Cited by 104
Danger Signaling in Atherosclerosis
Zimmer, S., Grebe, A., & Latz, E. (2015) · Circulation Research · doi:10.1161/circresaha.116.301135 · Cited by 106
Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis
Stancu, C. S., Toma, L., & Sima, A. V. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1437-1 · Cited by 110
Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis
Gleissner, C. A., Leitinger, N., & Ley, K. F. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089854 · Cited by 103
CD36 Binds Oxidized Low Density Lipoprotein (LDL) in a Mechanism Dependent upon Fatty Acid Binding
Jay, A. G., Chen, A. N., Paz, M. A., Hung, J. P., & Hamilton, J. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627026 · Cited by 99
Wang, L., Huang, Z., Huang, W., Chen, X., Shan, P., Zhong, P., Khan, Z. A., Wang, J., Fang, Q., Liang, G., et al. (2017) · Scientific Reports · doi:10.1038/srep45917 · Cited by 96
Endoplasmic reticulum stress and lipid dysregulation
Colgan, S. M., Al‐Hashimi, A., & Austin, R. C. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001742 · Cited by 97
NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 96
Stephen, S. L., Freestone, K., Dunn, S., Twigg, M. W., Homer‐Vanniasinkam, S., Walker, J. H., Wheatcroft, S. B., & Ponnambalam, S. (2010) · International Journal of Hypertension · doi:10.4061/2010/646929 · Cited by 97
Gibson, F. C. (2007) · Frontiers in bioscience · doi:10.2741/2822 · Cited by 93
Iacobini, C., Menini, S., Ricci, C., Scipioni, A., Sansoni, V., Cordone, S., Taurino, M., Serino, M., Marano, G., Federici, M., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186791 · Cited by 91
Kim, E., Tolhurst, A. T., Qin, L. Y., Chen, X.-Y., Febbraio, M., & Cho, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0982-08.2008 · Cited by 81
Zhang, Y., Li, Q., Welsh, W. J., Moghe, P. V., & Uhrich, K. E. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.028 · Cited by 87
Lipid scavenging macrophages and inflammation
Vogel, A., Brunner, J. S., Hajto, A., Sharif, O., & Schabbauer, G. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159066 · Cited by 92
Sjöberg, B. G., Su, J., Dahlbom, I., Grönlund, H., Wikström, M., Hedblad, B., Berglund, G. L., Fairé, U. D., & Frostegård, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.009 · Cited by 87
Biocompatibility of total joint replacements: A review
Goodman, S. B., Gómez‐Barrena, E., Takagi, M., & Konttinen, Y. T. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32063 · Cited by 91
Wang, S., Wu, D., Matthan, N. R., Lamon‐Fava, S., Lecker, J. L., & Lichtenstein, A. H. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.024 · Cited by 85
Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys
Tang, C., Kanter, J. E., Bornfeldt, K., LeBoeuf, R. C., & Oram, J. F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m003525 · Cited by 85
Shrestha, S., Ehlers, S. J., Lee, J., Fernández, M. L., & Koo, S. I. (2009) · Journal of Nutrition · doi:10.3945/jn.108.103341 · Cited by 85
CXCL16/SR-PSOX—A friend or a foe in atherosclerosis?
Sheikine, Y., & Sirsjö, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.034 · Cited by 82
Jagavelu, K., Tietge, U. J. F., Gaestel, M., Drexler, H., Schieffer, B., & Bavendiek, U. (2007) · Circulation Research · doi:10.1161/circresaha.107.156075 · Cited by 78
Sun, B., Boyanovsky, B. B., Connelly, M. A., Shridas, P., van der Westhuyzen, D. R., & Webb, N. R. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700163-jlr200 · Cited by 80
Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis
Liu, Z., Zhu, H., Dai, X., Wang, C., Ding, Y., Song, P., & Zou, M. (2017) · Circulation Research · doi:10.1161/circresaha.117.311546 · Cited by 79
Lin, J., Shou, X., Mao, X., Dong, J., Mohabeer, N., Kushwaha, K. K., Wang, L., Su, Y., Fang, H., & Li, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062148 · Cited by 79
The TNF-Like Protein 1A–Death Receptor 3 Pathway Promotes Macrophage Foam Cell Formation In Vitro
McLaren, J. E., Calder, C. J., McSharry, B. P., Sexton, K., Salter, R. C., Singh, N. N., Wilkinson, G. W. G., Wang, E. C. Y., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903782 · Cited by 79
Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis
Lien, C., Chen, S., Tsai, M., & Lin, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716332 · Cited by 77
A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation
Lee, J., Lim, E., Park, D., Lee, S.-H., Kim, J.-R., & Baek, S. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.022 · Cited by 76
Iacobini, C., Menini, S., Ricci, P. C., Scipioni, A., Sansoni, V., Mazzitelli, G., Cordone, S., Pesce, C. M., Pugliese, F. R., Pricci, F., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2536 · Cited by 76
Ding, X., Zheng, L., Yang, B., Wang, X., & Yin, Y. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s207185 · Cited by 75
Immunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 73
Polymer‐based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis
Lewis, D. R., Kamisoglu, K., York, A. W., & Moghe, P. V. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.145 · Cited by 74
MK2: a novel molecular target for anti-inflammatory therapy
Duraisamy, S., Bajpai, M., Bughani, U., Dastidar, S. G., Ray, A., & Chopra, P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.921 · Cited by 77
Zhang, X., Centurion, F., Misra, A., Patel, S., & Gu, Z. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114709 · Cited by 76
Pathways of smooth muscle foam cell formation in atherosclerosis
Pryma, C. S., Ortega, C., Dubland, J. A., & Francis, G. A. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000574 · Cited by 72
The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health
Bui, T. V. A., Hwangbo, H., Lai, Y., Hong, S. B., Choi, Y.-J., Park, H., & Ban, K. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2023.0048 · Cited by 70
Myeloid cells in atherosclerosis: initiators and decision shapers
Soehnlein, O., & Weber, C. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0141-z · Cited by 70
Zhou, M.-S., Chadipiralla, K., Mendez, A. J., Jaimes, E. A., Silverstein, R. L., Webster, K. A., & Raij, L. R. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00042.2013 · Cited by 78
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk
Fullerton, M. D., Ford, R. J., McGregor, C., LeBlond, N. D., Snider, S. A., Stypa, S., Day, E. A., Lhoták, Š., Schertzer, J. D., Austin, R. C., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m058875 · Cited by 70
Suzuki, Y., Tada‐Oikawa, S., Ichihara, G., Yabata, M., Izuoka, K., Suzuki, M., Sakai, K., & Ichihara, S. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.010 · Cited by 70
Wallet, S. M., Puri, V., & Gibson, F. C. (2018) · Vaccines · doi:10.3390/vaccines6020021 · Cited by 69
Nanotechnology applications for cardiovascular disease treatment: Current and future perspectives
Wang, D. K., Rahimi, M., & Filgueira, C. S. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102387 · Cited by 71
Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression
Cui, K., Gao, X., Wang, B., Wu, H., Kulandaisamy, A., Dong, Y., Xiao, Y., Jiang, X., Malovichko, M. V., Li, K. S., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321723 · Cited by 70
Su, J., Hua, X., Vikström, M., Leander, K., Gigante, B., Hellénius, M.-L., Fairé, U. D., & Frostegård, J. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-1 · Cited by 68
Role of Scavenger Receptor A Family in Lung Inflammation from Exposure to Environmental Particles
Thakur, S. A., Hamilton, R. F., & Holian, A. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910802085863 · Cited by 66
Segers, F. M., den Adel, B., Bot, I., van der Graaf, L. M., van der Veer, E. P., Gonzalez, W., Raynal, I., de Winther, M. P. J., Wodzig, W. K. W. H., Poelmann, R. E., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300707 · Cited by 66
The Role of Macrophage Lipophagy in Reverse Cholesterol Transport
Jeong, S.-J., Lee, M.-N., & Oh, G. T. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.1.41 · Cited by 65
Zheng, G., Zhao, Y., Li, Z., Hua, Y., Zhang, J., Miao, Y., Guo, Y., Li, L., Shi, J., Dong, Z., et al. (2023) · Theranostics · doi:10.7150/thno.80250 · Cited by 66
Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease
Okamura, D. M., & Himmelfarb, J. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1199-5 · Cited by 63
Chistiakov, D. A., Ревин, В. В., Sobenin, I. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150226114031 · Cited by 71
From proliferation to proliferation: monocyte lineage comes full circle
Świrski, F. K., Hilgendorf, I., & Robbins, C. S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0409-1 · Cited by 69
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential
Di, L., & Maiseyeu, A. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1886199 · Cited by 63
Niacin improves renal lipid metabolism and slows progression in chronic kidney disease
Cho, K.-H., Kim, H.-J., Kamanna, V. S., & Vaziri, N. D. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.10.009 · Cited by 63
Usui, F., Kimura, H. J., Ohshiro, T., Tatsumi, K., Kawashima, A., Nishiyama, A., Iwakura, Y., Ishibashi, S., & Takahashi, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.117 · Cited by 62
Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis
Milioti, N., Bermúdez-Fajardo, A., Penichet, M. L., & Oviedo‐Orta, E. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/723539 · Cited by 62
Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis
Rojas, J., Salazar, J. J., Martínez, M. S., Palmar, J., Bautista, J., Chávez-Castillo, M., Gómez, A., & Bermúdez, V. (2015) · Scientifica · doi:10.1155/2015/851252 · Cited by 65
Fan, J. J., Liu, L., Liu, Q., Cui, Y., Yao, B., Zhang, M., Gao, Y., Fu, Y., Dai, H., Pan, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07895-3 · Cited by 62
Li, T., Zhi-Bin, W. A. N. G., Yang, L., Feng, C. A. O., Yang, B., & Kuang, H. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30048-2 · Cited by 61
Zhang, J., Nie, S., Martı́nez–Zaguilán, R., Sennoune, S. R., & Wang, S. F. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.001 · Cited by 60
Applying nanomedicine in maladaptive inflammation and angiogenesis
Alaarg, A., Pérez‐Medina, C., Metselaar, J. M., Nahrendorf, M., Fayad, Z. A., Storm, G., & Mulder, W. J. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.009 · Cited by 60
Gleissner, C. A., Sanders, J. M., Nadler, J. L., & Ley, K. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158295 · Cited by 58
Wang, M., Kiss, R. S., Franklin, V., McBride, H. M., Whitman, S. C., & Marcel, Y. L. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600470-jlr200 · Cited by 59
Dai, X.-Y., Cai, Y., Mao, D.-D., Qi, Y., Tang, C., Xu, Q., Zhu, Y., Xu, M., & Wang, X. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.07.006 · Cited by 57
Effect of the oxLDL Binding Protein Fc-CD68 on Plaque Extension and Vulnerability in Atherosclerosis
Zeibig, S., Li, Z., Wagner, S., Holthoff, H., Ungerer, M., Bültmann, A., Uhland, K., Vogelmann, J., Simmet, T., Gawaz, M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.240515 · Cited by 56
The Vascular Biology of Atherosclerosis
Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00043-3 · Cited by 57
Yamagata, K., Hashiguchi, K., Yamamoto, H., & Tagami, M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000747 · Cited by 57
Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis
Liu, Y., Yuan, P.-Z., Wu, J., & Hu, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02109-8 · Cited by 56
Li, Y., Zhou, M., Li, H., Dai, C., Yin, L., Liu, C., Li, Y., Zhang, E., Dong, X., Ji, H., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad796 · Cited by 55
Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
Stöger, J. L., Goossens, P., & de Winther, M. P. J. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110790886983 · Cited by 54
Stiebing, C., Meyer, T., Rimke, I., Matthäus, C., Schmitt, M. P., Stefan Lorkowski, A., & Popp, J. (2017) · Journal of Biophotonics · doi:10.1002/jbio.201600279 · Cited by 55
Parks, B. W., Lusis, A. J., & Kabarowski, J. H. S. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000246774.02426.71 · Cited by 55
Tahir, U. A., Katz, D. H., Ávila-Pacheco, J., Bick, A. G., Pampana, A., Robbins, J., Yu, Z., Chen, Z., Benson, M. D., Cruz, D. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32275-3 · Cited by 52
Ohwaki, K., Bujo, H., Jiang, M., Yamazaki, H., Schneider, W. J., & Saitō, Y. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.137091 · Cited by 54
PRR Function of Innate Immune Receptors in Recognition of Bacteria or Bacterial Ligands
Gulati, A., Kaur, D., Prasad, G. V. R. K., & Mukhopadhaya, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3065-0_18 · Cited by 61
Budoff, M. J., Lakshmanan, S., Toth, P. P., Hecht, H. S., Shaw, L. J., Maron, D. J., Michos, E. D., Williams, K. A., Sr., Nasir, K., Choi, A., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100318 · Cited by 54
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Wang, S., He, H., Mao, Y., Zhang, Y., & Gu, N. (2024) · Advanced Science · doi:10.1002/advs.202308298 · Cited by 59
Gabunia, K., Ellison, S. P., Kelemen, S. E., Kako, F., Cornwell, W. D., Rogers, T. J., Datta, P. K., Ouimet, M. I., Moore, K. J., & Autieri, M. V. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.12.023 · Cited by 53
Self-citationZhao, Z.-W., Zhang, M., Chen, L., Gong, D., Xia, X.-D., Yu, X.-H., Wang, S., Ou, X., Dai, X.-Y., Zheng, X., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.011 · Cited by 53
Swiatlowska, P., Tipping, W. J., Marhuenda, E., Severi, P., Fomin, V., Yang, Z., Xiao, Q., Graham, D., Shanahan, C. M., & Iskratsch, T. (2023) · Advanced Science · doi:10.1002/advs.202308686 · Cited by 52
Liu, H., Pietersz, G. A., Peter, K., & Wang, X. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01279-y · Cited by 53
Zong, P., Feng, J., Yue, Z., Yu, A. S., Vacher, J., Jellison, E. R., Miller, B. A., Mori, Y., & Yue, L. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00027-7 · Cited by 51
Therapeutic approaches to drug targets in atherosclerosis
Jamkhande, P. G., Chandak, P. G., Dhawale, S. C., Barde, S. R., Tidke, P. S., & Sakhare, R. S. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.04.005 · Cited by 53
Polykratis, A., Loo, G., Xanthoulea, S., Hellmich, M., & Pasparakis, M. (2012) · Circulation · doi:10.1161/circulationaha.112.100339 · Cited by 50
Lemos, B. S., Vera, I., Blesso, C. N., & Fernández, M. L. (2018) · Nutrients · doi:10.3390/nu10020258 · Cited by 51
Xiang, P., Blanchard, V., & Francis, G. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.921597 · Cited by 53
Nur77 Decreases Atherosclerosis Progression in apoE−/− Mice Fed a High-Fat/High-Cholesterol Diet
Hu, Y., Zhang, P., Yang, J., Huang, J.-L., Ma, X., Li, S., Zhao, J., Hu, Y.-R., Wang, Y., Gao, J.-J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087313 · Cited by 50
Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure
Moradi, H., Yuan, J. J., Ni, Z., Norris, K. C., & Vaziri, N. D. (2009) · American Journal of Nephrology · doi:10.1159/000210020 · Cited by 50
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis
Bertrand, M.-J., & Tardif, J. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2017.1269743 · Cited by 52
Liao, D., Wang, X., Li, M., Lin, P. H., Yao, Q. C., & Chen, C. (2008) · Blood · doi:10.1182/blood-2008-05-158048 · Cited by 49
Hofnagel, O., Luechtenborg, B., Weißen-Plenz, G., & Robenek, H. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.06.003 · Cited by 48
The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease
Bezhaeva, T., Karper, J. C., Quax, P. H. A., & de Vries, M. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.820962 · Cited by 48
Rahaman, S. O., Swat, W., Febbraio, M., & Silverstein, R. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192450 · Cited by 47
Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells
Yew, K.-H., Carsten, B., & Harrison, C. J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.10.009 · Cited by 47
Lemos, B. S., Vera, I., Malysheva, O., Caudill, M. A., & Fernández, M. L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1466213 · Cited by 46
Zhuang, J., Liu, Y., Li, Z., Zhuang, Q.-Z., Tang, W., Xiong, Y., & Huang, X. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115733 · Cited by 45
The cell origins of foam cell and lipid metabolism regulated by mechanical stress in atherosclerosis
Ouyang, Z., Zhong, J., Shen, J., & Zeng, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1179828 · Cited by 44
Kuniyasu, A., Tokunaga, M., Yamamoto, T., Inoue, S., Obama, K., Kawahara, K., & Nakayama, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.011 · Cited by 44
Metadata
- Authors
- Moore, K. J., & Freeman, M. W.
- Affiliations
- Harvard University (US)
- Venue
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2006-08
- Volume
- 26
- Issue
- 8
- Pages
- 1702-1711
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2093979977
- Cited by
- 562
- References
- 94
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 26 · 2023: 25 · 2022: 32 · 2021: 30 · 2020: 23 · 2019: 27 · 2018: 22 · 2017: 16 · 2016: 26 · 2015: 27 · 2014: 28 · 2013: 36 · 2012: 37
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- scavenger receptors, atherosclerosis, modified low-density lipoprotein, foam cells, cholesterol accumulation, foam cell formation, lipid uptake, sterile inflammation, pattern recognition receptors, efferocytosis, signal transduction, atherogenesis
- MeSH terms
- Animals, Humans, Atherosclerosis, Lipid Metabolism, Receptors, Scavenger
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review